91. The Psychedelic Industry with Josh Hardman

Josh Hardman, founder of Psychedelic Alpha, discusses the challenges faced by the psychedelic industry including progress of decriminalisation, clinical trial milestones, and the potential evolution of the industry. They also touch on the current state of decriminalization in Oregon and Colorado, challenges in accessing regulated psilocybin, real-world evidence collection, drug development models, and the importance of in-person events in the psychedelic industry.